Targeting Mitochondrial Dysfunction for Bipolar Disorder.

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Current topics in behavioral neurosciences

• Publication date

  2021-02-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/7854_2020_152PMID 33580439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maternal Nicotinamide Riboside Enhances Postpartum Weight Loss, Juvenile Offspring Development, and Neurogenesis of Adult Offspring.

  2019cited by this paper
• Pterostilbene, an active component of the dragon’s blood extract, acts as an antidepressant in adult rats

  2019cited by this paper
• Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature

  2019cited by this paper
• Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease

  2019cited by this paper
• Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults

  2019cited by this paper
• A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

  2019cited by this paper
• Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases.

  2019cited by this paper
• Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury

  2019cited by this paper
• Ketosis and bipolar disorder: controlled analytic study of online reports

  2019cited by this paper
• Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview

  2019cited by this paper
• The effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials.

  2019cited by this paper
• Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia.

  2019cited by this paper
• Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials

  2019cited by this paper
• Prevalence and Correlates of Vitamin D Deficiency in a Sample of 290 Inpatients With Mental Illness

  2019cited by this paper
• Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial.

  2019cited by this paper
• Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms

  2019cited by this paper
• Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders

  2019cited by this paper
• The effect of alpha‐lipoic acid on inflammatory mediators: a systematic review and meta‐analysis on randomized clinical trials

  2019cited by this paper
• Physiologic Implications of Reactive Oxygen Species Production by Mitochondrial Complex I Reverse Electron Transport

  2019cited by this paper
• Efficacy of vitamin D supplementation in major depression: A meta-analysis of randomized controlled trials

  2019cited by this paper
• Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder

  2019cited by this paper
• Adjunctive minocycline for major mental disorders: A systematic review

  2019cited by this paper
• The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia

  2019cited by this paper
• Oxidative stress: the lowest common denominator of multiple diseases

  2019cited by this paper
• Current understanding of bipolar disorder: Toward integration of biological basis and treatment strategies

  2019cited by this paper
• Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

  2019cited by this paper
• Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein

  2018cited by this paper
• Lactate in bipolar disorder: A systematic review and meta‐analysis

  2018cited by this paper
• Resveratrol and Brain Mitochondria: a Review

  2018cited by this paper
• Different approaches to modeling analysis of mitochondrial swelling.

  2018cited by this paper
• The Relationship between the Number of Manic Episodes and Oxidative Stress Indicators in Bipolar Disorder

  2018cited by this paper
• Optimal vitamin D spurs serotonin: 1,25-dihydroxyvitamin D represses serotonin reuptake transport (SERT) and degradation (MAO-A) gene expression in cultured rat serotonergic neuronal cell lines

  2018cited by this paper
• Exploring the relationship between vitamin D and mania: correlations between serum vitamin D levels and disease activity

  2018cited by this paper
• Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients’ responsiveness to lithium

  2018cited by this paper
• Clinical syndromes associated with Coenzyme Q10 deficiency.

  2018cited by this paper
• So Happy Together: The Storied Marriage Between Mitochondria and the Mind.

  2018cited by this paper
• Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases

  2018cited by this paper
• Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial.

  2018cited by this paper
• Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)

  2018cited by this paper
• Resveratrol, pterostilbene, and dementia

  2018cited by this paper
• Dynamic Changes of the Mitochondria in Psychiatric Illnesses: New Mechanistic Insights From Human Neuronal Models.

  2018cited by this paper
• Oxidative stress, aging, and diseases

  2018cited by this paper
• Mitochondria modulate programmed neuritic retraction

  2018cited by this paper
• Mitochondrial Agents for Bipolar Disorder

  2018cited by this paper
• TSPO upregulation in bipolar disorder and concomitant downregulation of mitophagic proteins and NLRP3 inflammasome activation

  2018cited by this paper
• Vitamin D Receptor Is Necessary for Mitochondrial Function and Cell Health

  2018cited by this paper
• Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment

  2018cited by this paper
• Ant1 mutant mice bridge the mitochondrial and serotonergic dysfunctions in bipolar disorder

  2018cited by this paper
• A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.

  2018cited by this paper
• A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorder

  2018cited by this paper
• Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes.

  2018cited by this paper
• The Complex Interaction of Mitochondrial Genetics and Mitochondrial Pathways in Psychiatric Disease

  2018cited by this paper
• Alpha-lipoic acid in the treatment of psychiatric and neurological disorders: a systematic review

  2018cited by this paper
• Lithium-associated anterior cingulate neurometabolic profile in euthymic Bipolar I disorder: A 1H-MRS study.

  2018cited by this paper
• Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies

  2018cited by this paper
• Resveratrol and Depression in Animal Models: A Systematic Review of the Biological Mechanisms

  2018cited by this paper
• The observed alteration in BCL2 expression following lithium treatment is influenced by the choice of normalization method

  2018cited by this paper
• High Vitamin C Status Is Associated with Elevated Mood in Male Tertiary Students

  2018cited by this paper
• Evaluating the Effect of Coenzyme Q10 Augmentation on Treatment of Bipolar Depression: A Double-Blind Controlled Clinical Trial

  2018cited by this paper
• Differential mitochondrial DNA copy number in three mood states of bipolar disorder

  2018cited by this paper
• Salivary glutathione in bipolar disorder: A pilot study.

  2018cited by this paper
• Mitochondrial ATP production provides long-range control of endothelial inositol trisphosphate–evoked calcium signaling

  2018cited by this paper
• Possible SAMe-induced mania

  2018cited by this paper
• Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study.

  2018cited by this paper
• A systematic meta-analysis of oxygen-to-glucose and oxygen-to-carbohydrate ratios in the resting human brain

  2018cited by this paper
• Ebselen protects mitochondrial function and oxidative stress while inhibiting the mitochondrial apoptosis pathway after acute spinal cord injury.

  2018cited by this paper
• Emerging roles of mitochondria in synaptic transmission and neurodegeneration.

  2018cited by this paper
• Mitochondrial DNA copy number of peripheral blood in bipolar disorder: The present study and a meta-analysis.

  2018cited by this paper
• Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments.

  2018cited by this paper
• Melatonin and the electron transport chain

  2017cited by this paper
• Oxidative Stress: Harms and Benefits for Human Health

  2017cited by this paper
• Antidepressant effect of taurine in chronic unpredictable mild stress-induced depressive rats

  2017cited by this paper
• Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?

  2017cited by this paper
• Beyond the therapeutic shackles of the monoamines: New mechanisms in bipolar disorder biology

  2017cited by this paper
• Vitamin D supplementation in bipolar depression: A double blind placebo controlled trial.

  2017cited by this paper
• Metabotropic glutamate receptors as emerging research targets in bipolar disorder.

  2017cited by this paper
• Mitochondrial Etiology of Neuropsychiatric Disorders.

  2017cited by this paper
• A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression

  2017cited by this paper
• More Insight into BDNF against Neurodegeneration: Anti-Apoptosis, Anti-Oxidation, and Suppression of Autophagy

  2017cited by this paper
• Effects of coenzyme Q10 supplementation on inflammatory markers: A systematic review and meta‐analysis of randomized controlled trials

  2017cited by this paper
• Bezafibrate prevents mitochondrial dysfunction, antioxidant system disturbance, glial reactivity and neuronal damage induced by sulfite administration in striatum of rats: Implications for a possible therapeutic strategy for sulfite oxidase deficiency.

  2017cited by this paper
• The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment

  2017cited by this paper
• Biological hypotheses and biomarkers of bipolar disorder

  2017cited by this paper
• Vitamin C: An Antioxidant Agent

  2017cited by this paper
• Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges

  2017cited by this paper
• Mitochondrial dynamics in neuronal injury, development and plasticity

  2017cited by this paper
• Coenzyme Q10 in the Treatment of Mitochondrial Disease

  2017cited by this paper
• Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas

  2017cited by this paper
• A model of the mitochondrial basis of bipolar disorder.

  2017cited by this paper
• The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome

  2017cited by this paper
• Abnormalities in High-Energy Phosphate Metabolism in First-Episode Bipolar Disorder Measured Using 31P-Magnetic Resonance Spectroscopy.

  2017cited by this paper
• Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury

  2017cited by this paper
• Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial

  2016cited by this paper
• PPAR-γ Agonists for the Treatment of Major Depression: A Review

  2016cited by this paper
• Retinol as electron carrier in redox signaling, a new frontier in vitamin A research.

  2016cited by this paper
• The neurobiology of acetyl-L-carnitine.

  2016cited by this paper
• Dorsal Anterior Cingulate Lactate and Glutathione Levels in Euthymic Bipolar I Disorder: 1H-MRS Study

  2016cited by this paper
• ROS and ROS-Mediated Cellular Signaling

  2016cited by this paper
• The Warburg Effect: How Does it Benefit Cancer Cells?

  2016cited by this paper
• Thiobarbituric Acid-Reactive Substances: Markers of an Acute Episode and a Late Stage of Bipolar Disorder

  2016cited by this paper

• Identifying and targeting abnormal mitochondrial localization associated with psychosis

  2026cites this paper
• Future Pharmacotherapy for Bipolar Disorders: Emerging Trends and Personalized Approaches

  2025cites this paper
• Chronic stress dysregulates the Hippo/YAP/14-3-3η pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression

  2024cites this paper
• The effects of ketogenic metabolic therapy on mental health and metabolic outcomes in schizophrenia and bipolar disorder: a randomized controlled clinical trial protocol

  2024cites this paper
• Linking mitochondrial dysfunction, neurotransmitter, neural network abnormalities and mania: Elucidating neurobiological mechanisms of the therapeutic effect of the ketogenic diet in Bipolar Disorder.

  2024cites this paper
• Research progress in mitochondrial quality control in schizophrenia.

  2024cites this paper
• Mitochondrial Health Index Correlates with Plasma Circulating Cell-Free Mitochondrial DNA in Bipolar Disorder

  2023cites this paper
• Endo-Lysosomal and Autophagy Pathway and Ubiquitin-Proteasome System in Mood Disorders: A Review Article

  2023cites this paper
• Mitochondrial health index correlates with plasma circulating cell-free mitochondrial DNA in bipolar disorder

  2023cites this paper
• Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania

  2022cites this paper
• Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress–Induced Damage in Patients with Bipolar Disorder

  2022cites this paper
• Targeting mitochondria in dermatological therapy: beyond oxidative damage and skin aging

  2022cites this paper
• Associations between oxidative stress markers and patient-reported smartphone-based symptoms in patients newly diagnosed with bipolar disorder: An exploratory study.

  2022cites this paper
• Associations between levels of oxidative nucleoside damage and cardiovascular risk in patients newly diagnosed with bipolar disorder and their unaffected relatives

  2022cites this paper
• Assessing the joint effects of mitochondrial function and human behavior on the risks of anxiety and depression.

  2022cites this paper
• Selective Serotonin Reuptake Inhibitor Citalopram Ameliorates Cognitive Decline and Protects Against Amyloid Beta-induced Mitochondrial Dynamics, Biogenesis, Autopahgy, Mitophagy and Synaptic Toxicities in a Mouse Model of Alzheimer's Disease.

  2021cites this paper
• Comparative efficacy of mitochondrial agents for bipolar disorder during depressive episodes: a network meta-analysis using frequentist and Bayesian approaches

  2021cites this paper